Top Markets
#1 Seeker Seeker +18.80%
#2 EXOD EXOD +9.04%
#3 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.47%
#4 Arowana Arowana +5.88%
#5 MetaDAO MetaDAO +4.67%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +4.02%
#7 Mina Protocol Mina Protocol +3.88%
#8 Pons Pons +3.00%
#9 Solstice Solstice +2.88%
#10 Official Trump Official Trump +2.75%
Coin of the day
Seeker Seeker
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

ALPN
Clasificación en acciones #6581
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company... Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.
Precio por acción
$64.97
Última sincronización: 2024-05-20
Capitalización bursátil
$1.97B
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Alpine Immune Sciences, Inc. (ALPN)

Categoría

Healthcare
Margen Operativo de Alpine Immune Sciences, Inc. (ALPN)
Margen Operativo al August 2026 TTM: -75.16%
Según los informes financieros más recientes y el precio de las acciones de Alpine Immune Sciences, Inc., el margen operativo actual (TTM) es -75.16%. Al final de 2022, el margen operativo era -193.41%.
Historial de Margen Operativo de Alpine Immune Sciences, Inc. desde 2012 hasta 2026
Margen Operativo al final de cada año
Año Margen Operativo Cambiar
2026 (TTM) -75.16% 0.00%
2023 -75.16% -61.14%
2022 -193.41% -9.06%
2021 -212.68% -30.94%
2020 -307.97% -87.70%
2019 -2,504.25% -53.33%
2018 -5,365.96% 520.31%
2017 -865.05% -20.01%
2016 -1,081.42% -76.76%
2015 -4,654.07% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
Margen Operativo de empresas similares o competidoras
Empresa Margen Operativo Diferencia de Margen Operativo País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -100.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -100.38%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -100.34%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -98.02%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
¿Qué es el Margen Operativo de una empresa?
El Margen Operativo es un indicador clave para evaluar la rentabilidad de una empresa. Un margen operativo más alto suele ser mejor, ya que indica que una empresa puede vender sus productos o servicios por mucho más de lo que cuestan producirlos. Se calcula dividiendo las ganancias de la empresa entre sus ingresos.